SCHEMBL3412427

SCHEMBL3412427

CCOc1cccc2c1C(N)CO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.41
HTR2A P28223 4/20 0.40
HTR2C P28335 4/20 0.40
HTR2B P41595 3/20 0.40
HTR1A P08908 3/20 0.38
TSHR P16473 1/20 0.38
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
HTR1B P28222 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
PABPC1 P11940 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2240288 0.83 HTR1A (0.44) ALDH1A1HTR2AHTR2CHTR1ATSHR
SCHEMBL1922464 0.83 HTR1A (0.44) ALDH1A1HTR2AHTR2CHTR1ATSHR
SCHEMBL3408454 0.83 ADRA1D (0.38) ALDH1A1HTR2CHTR2BHTR1ATSHR
SCHEMBL1266571 0.70 CYP19A1 (0.38) HTR2CHTR2BCYP2D6
SCHEMBL28731754 0.70 CA2 (0.41) HTR2AHTR2CHTR1ACYP2D6SLC6A2
Hydrochloric Acid SCHEMBL30818117 0.69 HTR2C (0.40) HTR2CHTR2BCYP2D6
SCHEMBL13534203 0.68 AOC3 (0.54) NPC1ALDH1A1HTR1AMEN1KMT2A
SCHEMBL20978627 0.68 MTNR1A (0.60) NPC1ALDH1A1HTR1ATSHRSLC6A4
SCHEMBL19829900 0.68 MAP3K14 (0.45) HTR2AHTR1ADRD2
SCHEMBL14661235 0.67 GRM2 (0.34) ALDH1A1KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
EP-2262789-A1 2-AMINOQUINOLINES F. Hoffmann-La Roche AG (CH) 2010-12-22 EP disclosed
WO-2009109477-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A NPC1 2931/4885ALDH1A1 1203/4885HTR2A 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.